Shareholder Alert: Ademi LLP Investigates Disclosure Issues Involving ARCA Biopharma, Inc.'s Transaction With Oruka
Shareholder Alert: Ademi LLP Investigates Disclosure Issues Involving ARCA Biopharma, Inc.'s Transaction With Oruka
MILWAUKEE, June 4, 2024 /PRNewswire/ -- Ademi LLP is investigating ARCA (NASDAQ: ABIO) for possible breaches of fiduciary duty and other violations of law in its transaction with Oruka.
Ademi LLP正在調查ARCA（NASDAQ: ABIO）可能存在的違反信託責任和其他違法行爲的問題，以及其與Oruka的交易。.
Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
點擊這裏了解如何加入或者免費撥打Guri Ademi的電話號碼866-264-3995。您沒有任何費用或者義務。
In the transaction, ARCA stockholders will own approximately 2.38% and Oruka stockholders will own approximately 97.62% of the combined company. Certain stockholders of ARCA holding approximately 28.5% of the outstanding shares of ARCA common stock have entered into support agreements with ARCA and Oruka to vote all of their shares of ARCA common stock in favor of the transaction and against any alternative acquisition proposals. ARCA insiders will receive substantial benefits as part of change of control arrangements.
在此交易中，ARCA股東將擁有合併後公司的約2.38％，而Oruka股東將擁有約97.62％。持有ARCA普通股傑出股份約28.5％的某些ARCA股東已簽訂支持協議，承諾全票支持交易並反對任何替代收購方案。ARCA內部人員將在控制權變更安排中獲得大量利益。
We are investigating the conduct of ARCA's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We are also investigating certain disclosure issues involving the transaction.
我們正在調查ARCA的董事會行爲，以及他們是否履行了對所有股東的信託職責。我們還調查了與該交易有關的某些披露問題。
If you own ARCA common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or
如果您持有ARCA普通股並希望獲得更多信息，請通過[email protected]或免費電話：866-264-3995與Guri Ademi聯繫，或訪問
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
我們專門從事全國範圍內有關收購、合併和個人股東權利的股東訴訟。欲了解更多信息，請隨時與我們聯繫。律師廣告。之前的業績不保證類似的結果。
Contacts
聯繫方式
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
Ademi LLP
Guri Ademi
免費電話：(866) 264-3995
傳真：(414) 482-8001
SOURCE Ademi LLP
信息來源：Ademi LLP
譯文內容由第三人軟體翻譯。